Gene therapy strategies for hemophilia: benefits versus risks
Article first published online: 16 SEP 2010
Copyright © 2010 John Wiley & Sons, Ltd.
The Journal of Gene Medicine
Volume 12, Issue 10, pages 797–809, October 2010
How to Cite
Petrus, I., Chuah, M. and VandenDriessche, T. (2010), Gene therapy strategies for hemophilia: benefits versus risks. J. Gene Med., 12: 797–809. doi: 10.1002/jgm.1500
- Issue published online: 20 OCT 2010
- Article first published online: 16 SEP 2010
- Manuscript Accepted: 11 AUG 2010
- Manuscript Received: 23 JUL 2010
- EU FP6 PERSIST
- Bayer-Schering Pharma
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.